Gynecomastia and hypertension in a patient treated with posaconazole

Posaconazole therapy may lead to increased serum estradiol levels and development of gynecomastia. Early detection by endocrine hormone measurements may help preventing gynecomastia.

Detalles Bibliográficos
Autores principales: Thompson, George R., Surampudi, Prasanth N., Odermatt, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752548/
https://www.ncbi.nlm.nih.gov/pubmed/33363898
http://dx.doi.org/10.1002/ccr3.3376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752548/
https://www.ncbi.nlm.nih.gov/pubmed/33363898
http://dx.doi.org/10.1002/ccr3.3376

Ejemplares similares